Effect of Virtual Reality on Freezing Phenomenon, Balance, Functional Mobility, Participation in Parkinson's Patients
Effect of Task-Oriented Virtual Reality Access With Crowd Simulation on Freezing Phenomenon, Balance, Functional Mobility, Participation and Quality of Life in Parkinson's Patients
1 other identifier
interventional
20
1 country
3
Brief Summary
This study was planned to investigate the use and results of virtual reality applications with specially prepared software for the rehabilitation of freezing phenomenon, which increases the falling anxiety of individuals with Parkinson's disease and causes social isolation. Individuals over the age of 50 who have been diagnosed with idiopathic Parkinson's disease by a specialist neurologist will be included in the study; Individuals evaluated in terms of balance, functional mobility, freezing phenomenon, participation, and cognitive status will be randomly divided into two groups receiving conventional treatment and additional virtual reality. After the preliminary evaluation, they will receive 8 weeks of treatment 4 days a week and will be evaluated after the treatment and 3 months after the treatment. In addition to the improvements that will emerge as a result of the treatments within the scope of the study, it is expected that the virtual reality application created with crowd simulation will provide more effective results in improving the parameters. Knowing the effects of exercises in crowds, which cannot be performed in the clinic, in the treatment of Parkinson's disease patients, whose freezing and freezing-related symptoms are aggravated, especially in crowded environments, will make significant contributions to the field.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2024
CompletedFirst Posted
Study publicly available on registry
April 30, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedApril 30, 2024
April 1, 2024
1.5 years
April 19, 2024
April 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Freezing Phenomenon
The presence and severity of freezing in patients will be evaluated with the Freezing of Gait Questionnaire. It consists of six items and each item is evaluated with a 5-point Likert scale. In the scale, which was adapted into Turkish by Candan et al., the score range is 0-24 and high scores indicate that the condition associated with frostbite is poor.
Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit
Balance
The balance of the patients will be evaluated with the Biodex Balance System. Postural stability and fall risk will be evaluated.
Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit
Functional Mobility
The Timed Get Up and Go Test (TUG) will be used to assess functional mobility. The TUG, which includes walking and turning functions, has been shown to be highly reliable and valid for individuals with Parkinson's disease). The person to be tested sits on a chair at normal height. With the command "Go", the person is asked to get up from the chair and walk 3 m forward at a normal walking speed and then return and sit back on the chair. It is usually administered twice and the average time is recorded. The person is allowed to use an assistive device (if available) and this is noted.
Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit
Quality of Life Assessment
Quality of life will be assessed with Parkinson's Disease Questionnaire (PDQ-8) developed specifically for individuals with Parkinson's disease. This validated questionnaire consists of eight questions to assess mobility, activities of daily living, emotional well-being, disease stigma, social support, cognition, communication and physical discomfort . In the questionnaire, the status of the person in the last month is questioned. The total score is between 0 and 100, with lower scores indicating better perceived health status due to the disease.
Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit
Participation
In order to evaluate social participation in the study, home participation (grocery shopping, meal preparation, daily household chores, money management, etc.), social participation (hobby, going out of the house, etc.), productivity (school, work, volunteer activities, etc.), electronic A scale consisting of 43 social networks (internet use, social communication, mobile phone use, etc.), 4 subunits and a total of 18 questions will be used.
Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit
Secondary Outcomes (2)
Executive functions
Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit
The activity-specific balance confidence scale
Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit
Study Arms (2)
Conventional group
ACTIVE COMPARATORPatients in the conventional treatment group will be given 15 minutes of walking training in addition to the 45 minutes of conventional Parkinson's rehabilitation program. Patients in the conventional treatment group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors), stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Walking training to be given to the conventional group will include walking in different directions, walking with arm swing, walking over blocks, stopping and restarting walking, and changing direction activities.
Virtual reality group
EXPERIMENTALPatients in the virtual reality group will be given a 45-minute conventional Parkinson's rehabilitation program similar to those in the conventional group, followed by 15 minutes of virtual reality walking training. Patients in the virtual reality group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), Respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors) stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Virtual reality applications increase the sense of reality in the individual with enriched virtual environments where sensory inputs are increased and provide the opportunity to perform activity training with a rich variety of tasks.
Interventions
Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.
Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.
Eligibility Criteria
You may qualify if:
- Being diagnosed with Parkinson's disease by a qualified neurologist (diagnosed with idiopathic PD according to UK Brain Bank criteria
- Being between 1-2.5 stages according to the Hoehn and Yahr Staging Scale
- Volunteering to participate in the study
- years of age or older
- Standardized Mini Mental Test score greater than 24
- Patients experiencing an on-off period are in the "on" period
- Not using deep brain stimulation or drug pump
- Ability to walk independently on level ground (Functional Ambulation 3 and above according to classification)
- Having a score of (≥2) on item 3 of the freezing while walking scale
You may not qualify if:
- Being any neurological or psychiatric disease other than Parkinson's disease
- Cardiovascular, vestibular or musculoskeletal disease
- Dyskinetic movements
- Having vision problems that cannot be corrected with glasses or lenses
- Hearing problems that cannot be corrected with a hearing aid
- Using an assistive device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Gazi University
Ankara, Maltepe, 06570, Turkey (Türkiye)
Kirsehir Ahi Evran University
Kirşehi̇r, Merkez, 40100, Turkey (Türkiye)
Ankara Yildirim Beyazit University
Ankara, Çubuk, 06760, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ertuğrul DEMİRDEL, Assoc. Prof.
Ankara Yildirim Beyazıt University
- STUDY CHAIR
Özge BARUT ÇELİK, MSc.
Kirsehir Ahi Evran University
- PRINCIPAL INVESTIGATOR
Figen TUNCAY, Prof.
Kirsehir Ahi Evran University
- PRINCIPAL INVESTIGATOR
Öner BARUT, Asst. Prof.
Gazi University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
April 19, 2024
First Posted
April 30, 2024
Study Start
August 1, 2024
Primary Completion
February 1, 2026
Study Completion
April 1, 2026
Last Updated
April 30, 2024
Record last verified: 2024-04